[2] A Press New Zealand article quotes Peter Shepherd, a molecular medicine professor at Auckland University and expert in diabetes and obesity, saying the long-term impact of Ozempic could be huge for New Zealanders Also Associate Professor Hesham Al-Sallami, at the University of Otago, an expert on diabetes and obesity medication, believes if Ozempic or similar medicines were funded in New Zealand, it would take considerable pressure off the hospital system
Age spots, melasma, or other form of hyperpigmentation can potentially be lightened with kojic acid
The compound has not yet received regulatory approval and remains under evaluation in Phase 3 studies, which aim to determine its long-term safety profile, durability of weight reduction, and extended metabolic effects
Clearly, the sale of such products is a scam
Lower-cost entry points through compounded providers can improve long-term adherence, especially for patients without insurance coverage or high deductibles